Search

Search Constraints

You searched for: Author/Creator Nakano, Nobuaki

Search Results

1. A decrease in newly diagnosed patients with adult T-cell leukemia/lymphoma in Kagoshima, a highly endemic area of HTLV-1 in southwestern Japan. Issue 4 (21st March 2023)

2. CCR7 alterations associated with inferior outcome of adult T‐cell leukemia/lymphoma under mogamulizumab treatment. Issue 5 (6th September 2022)

3. Clinical significance of cutaneous adverse reaction to mogamulizumab in relapsed or refractory adult T‐cell leukaemia‐lymphoma. (3rd April 2017)

4. Clinical significance of the immunoglobulin G heavy‐chain repertoire in peripheral blood mononuclear cells of adult T‐cell leukaemia–lymphoma patients receiving mogamulizumab. (10th October 2021)

5. Clinical significance of TP53 mutations in adult T‐cell leukemia/lymphoma. (17th August 2021)

6. Cytomegalovirus reactivation is associated with increased mortality more than 100 days after allogeneic hematopoietic stem cell transplantation for adult T‐cell leukemia/lymphoma. Issue 5 (6th March 2019)

7. Does an increased probability of graft‐vs‐host disease improve the survival of patients with adult T‐cell leukemia‐lymphoma? A simulation analysis using a Markov model. Issue 3 (10th April 2019)

8. Effect of anti‐CCR4 monoclonal antibody (mogamulizumab) on adult T‐cell leukemia–lymphoma: Cutaneous adverse reactions may predict the prognosis. Issue 3 (March 2014)

9. HLA 1–3 antigen‐mismatched related peripheral blood stem cells transplantation using low‐dose antithymocyte globulin versus unrelated cord blood transplantation. Issue 3 (3rd January 2022)

10. Identification of putative noncanonical driver mutations in patients with essential thrombocythemia. (14th March 2023)